Oral contraceptive use has been associated with risk of Crohn's disease (CD) and ulcerative colitis (UC).
Objective
To determine whether this association is confounded or modified by other important lifestyle and reproductive factors.
Design
A prospective cohort study was carried out of 117,375 US women enrolled since 1976 in the Nurses Health Study I (NHS I) and 115,077 women enrolled since 1989 in the Nurses' Health Study II (NHS II) with no prior history of UC or CD. These women had provided information every 2 years, on age at menarche, oral contraceptive use, parity, menopause status and other risk factors. Diagnoses of CD and UC were confirmed by review of medical records. Cox proportional hazards models were used to calculate HRs and 95% CIs.
Results
Among 232,452 women with over 5,030,196 person-years of follow-up, 315 cases of CD and 392 cases of UC were recorded through 2007 in NHS II and 2008 in NHS I. Compared with never users of oral contraceptives, the multivariate-adjusted HRs for CD were 2.82 (95% CI 1.65 to 4.82) among current users and 1.39 (95% CI 1.05 to 1.85) among past users. The association between oral contraceptives and UC differed according to smoking history (pheterogeneity=0.04). Age at menarche, age at first birth and parity were not associated with risk of UC or CD.
Conclusion
In two large prospective cohorts of US women, oral contraceptive use was associated with risk of CD. The association between oral contraceptive use and UC was limited to women with a history of smoking.
PMID 22619368 22619368 DOI 10.1136/gutjnl-2012-302362 10.1136/gutjnl-2012-302362
Cite this article
Khalili, H., Higuchi, L. M., Ananthakrishnan, A., Richter, J., Feskanich, D., fuchs, C., & Chan, A. (2013). Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. *Gut*, *62*(8), 1153-1159. https://doi.org/10.1136/gutjnl-2012-302362
Khalili H, Higuchi LM, Ananthakrishnan A, Richter J, Feskanich D, fuchs C, et al. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut. 2013;62(8):1153-1159. doi:10.1136/gutjnl-2012-302362
Khalili, Hamed, et al. "Oral contraceptives, reproductive factors and risk of inflammatory bowel disease." *Gut*, vol. 62, no. 8, 2013, pp. 1153-1159.
Numerous epidemiological studies have been performed to determine factors that might contribute to the development of inflammatory bowel disease. Although the role of oral contraceptive agents in Croh...
A tubo-ovarian abscess (TOA) is a complication of pelvic inflammatory disease (PID) resulting from an ascending infection of the upper genital tract. It is characterized by an inflammatory mass involv...
Khoramdad M et al., 2022
Open Access
European Journal of Medical Research
Background: Identifying breast cancer risk factors is a critical component of preventative strategies for this disease. This study aims to identify modifiable and non-modifiable risk factors of breast...
van Bommel MHD et al., 2022Human Reproduction Update
Background: Increasing numbers of BReast CAncer (BRCA) 1 or 2 pathogenic variant (PV) carriers, who have an inherited predisposition to breast and ovarian cancer, are being identified. Among these wom...